Onix raises $5 million pre-seed for expert-built health AI
What's the deal? Montreal-based OnixDealroom has a profile for this one. Try Dealroom → has raised $5 million (roughly C$7 million) in pre-seed funding led by Alpha EdisonDealroom has a profile for this one. Try Dealroom →, with participation from Garage CapitalDealroom has a profile for this one. Try Dealroom →, Ride Home FundDealroom has a profile for this one. Try Dealroom →, and strategic investors Jeremy ZimmerDealroom has a profile for this one. Try Dealroom →, co-founder of UTADealroom has a profile for this one. Try Dealroom →, and JS Cournoyer, co-founder of Real Ventures. It is the company's first institutional capital.
What's the endgame? Onix builds what it calls Personal Intelligence, AI systems trained exclusively on licensed expert knowledge and governed by the experts themselves, rather than on the open internet. The funding will accelerate platform development, expert onboarding, and research as Onix heads to public availability.
Why now? The raise comes as more people turn to AI for health advice, and as trust and provenance become defining challenges for the industry. Onix recently partnered with Mila, the Montreal AI research institute founded by Yoshua Bengio, and was named one of Canada's Top 100 AI Startups for 2026 by ALL IN.
By the numbers: The round ranks in the 95th percentile among 825 seed-stage health deals in Canada, all-time. It is more than seven times the average Canadian pre-seed deal in 2025 and exceeds the average Canadian seed round, according to the Canadian Venture Capital and Private Equity Association.
What's behind the platform? Onix launched with a cohort of founding health and wellness experts, each running a personalised "onix" trained on their knowledge. New additions include an addiction recovery specialist, a sleep psychologist, and an integrative cardiologist. The company was co-founded by David Bennahum, a former WIREDDealroom has a profile for this one. Try Dealroom → contributing editor, and Dr. Nicholas Nadeau, who scaled humanoid robotics company 1X as chief technology officer.
What could go wrong? Onix stakes its pitch on trust in medical advice, a high-stakes domain where errors carry real consequences. Convincing users to rely on AI over human clinicians — and keeping expert knowledge accurate and current — remains unproven at scale.
"The next generation of AI will be defined by trust," said Nick Grouf, managing partner at Alpha Edison. "Onix has built a fundamentally different approach around human expertise and privacy. That's why we invested."
The signal: US investor participation in Canadian pre-seed deals fell from 23% in 2024 to 8% in 2025, making a US-led round in a Canadian startup a notable vote of confidence. It also underscores a growing bet that the value in health AI lies in verified, expert-owned knowledge rather than models trained on the average internet.
Read more: pr.augustabusinessdaily.com
Image credit: Onix
